This is a working overview of melanocortin, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-09-13. Anything still debated is marked as such rather than presented as settled.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Belongs to the melanocortin agonist family |
| Key substitutions | Nle4 and D-Phe7 | Improve resistance to enzymatic degradation |
| Molecular formula | C50H69N15O9 | Approximately 1024 g/mol |
| Regulatory status | Not approved as a medicine | Distributed as a research chemical |
| Common synonyms | Melanotan II, MT-II, MT-2 | Spelling varies across sources |
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
Identity testing for a synthetic peptide relies on several complementary methods. Reversed-phase high-performance liquid chromatography separates the target from related impurities and reports purity as a percentage of total peak area. Mass spectrometry confirms molecular mass and can reveal deletions or truncations. Amino acid analysis and peptide mapping provide sequence-level confirmation, while counter-ion content and residual solvents are measured separately. A purity figure alone does not establish identity, so a complete dataset combines chromatographic and spectrometric evidence.
Lyophilized peptide powder is generally stored frozen, protected from light and moisture. Tryptophan residues are susceptible to oxidation, and the lactam bridge can hydrolyze under strongly acidic or basic conditions. Solutions prepared for laboratory work degrade faster than dry powder, and repeated freeze-thaw cycles accelerate loss. Common practice is to aliquot solutions before freezing and to avoid alkaline buffers. Reported stability windows vary with concentration, buffer, and temperature, so exact shelf lives are method-specific rather than universal.
=== Act 1 === W.P. Inman, a Confederate soldier wounded at the Battle of Petersburg, decides to desert from the Confederate Army and return home to Ada Monroe, his beloved who lives at Black Cove Farm, in North Carolina. Inman is aware of the Home Guard, which hunts down deserters from the Confederate Army. The leader of the local Home Guard is Teague, who resorts to such practices as burying deserters alive. On his journey home, Inman meets Solomon Veasey, whom he stops from committing murder. Meanwhile, Ada, once privileged, leads a life of material desperation. Ada meets Ruby, a mountain woman who teaches Ada about hunting and surviving. Inman encounters Veasey again, near a river whilst fleeing the Home Guard, and bargains with him for passage across the river. However, their vessel capsizes and the two drift down the river. The next morning, Lila and her three sisters see Inman and Veasey. Lila's husband drugs the two men before giving them up to the Home Guard. Inman and Veasey are put on a chain gang of deserters. Back at Black Cove Farm, Ruby finds her estranged father, Stobrod, a fiddler. Strobod is trying to steal food. Ruby wants nothing to do with her father, although he asserts that he has reformed his ways. Teague approaches, and Ruby hides her father. She later orders her father to stay away from her. Inman starts an insurrection among the chain gang. The guards shoot the entire chain gang, with a wounded Inman as the only survivor, chained to six dead prisoners. He relives the day he bid Ada farewell, when he thought that the war would last but six months.
=== Glycerol intoxication === Excessive consumption by children can lead to glycerol intoxication. Symptoms of intoxication include hypoglycemia, nausea, and a loss of consciousness. While intoxication as a result of excessive glycerol consumption is rare and its symptoms generally mild, occasional reports of hospitalization have occurred. In the United Kingdom in August 2023, manufacturers of syrup used in slush ice drinks were advised to reduce the amount of glycerol in their formulations by the Food Standards Agency to reduce the risk of intoxication. A 2025 study reported that between 2018 and 2024, at least 21 children aged 2–7 in the UK and Ireland received emergency treatment for symptoms of glycerol intoxication following the consumption of slush ice drinks. Food Standards Scotland advises that slush ice drinks containing glycerol should not be given to children under the age of 4, owing to the risk of intoxication. It also recommends that businesses do not use free refill offers for the drinks in venues where children under the age of 10 are likely to consume them, and that products should be appropriately labelled to inform consumers of the presence of glycerol.
=== Mislabelled door swipe data === During the first trial, door swipe records were used to establish Letby's presence on the neonatal unit at the time of various incidents. In August 2024, the Crown Prosecution Service confirmed that swipe data for one of the unit's doors had been mislabelled, with entries and exits reversed. The CPS did not confirm whether data for other doors had been correctly labelled. Cheshire Police reviewed the use of the incorrect data and concluded that it had been relied upon in evidence relating to nine infants, although it played a central role only in the case of Child K, for whom Letby was not convicted at the first trial. A second door to the unit did not record entries or exits, meaning that swipe card data could not account for all movements into and out of the unit.
Sources: en.wikipedia.org
== Programs == Since 1999, CLASP has worked in over 50 countries on six continents. Some of CLASP's past program locations include Argentina, Brazil, Egypt, Fiji, Ghana, Poland, South Africa, Tunisia, and Uruguay. CLASP currently has programs in China, Brazil, Europe, Southeast Asia, East Africa, India, and the United States, collaborating with policymakers, regulators, and their stakeholders to facilitate the development and implementation of energy efficiency S&L. Additionally, CLASP has two global programs—Global Research and the SEAD Initiative—which create original technical research, facilitate information exchange among countries, and disseminate S&L best practices internationally. In 2021, 15 countries signed SEAD's Product Efficiency Call to Action, which aims to double the efficiency of lighting, residential cooling, residential refrigeration, and industrial electric motor systems globally by 2030.
==== Roll-to-roll ==== In 2014, a two-step roll-to-roll manufacturing process was announced. The first roll-to-roll step produces the graphene via chemical vapor deposition. The second step binds the graphene to a substrate.
=== Laboratory Accreditations === ISO 9001:2008 certification from British Standards Institution (BSI) National Accreditation Board for Testing and Calibration Laboratories (NABL), Ministry of Science and Technology, Government of India.
Sources: en.wikipedia.org
Endocrine glands derive from all three germ layers. The natural decrease in function of the female's ovaries during late middle age results in menopause. The efficiency of all endocrine glands seems to decrease gradually as ageing occurs. This leads to a generalized increase in the incidence of diabetes mellitus and a lower metabolic rate.
== Further reading == De Iuliis, Gerardo; Pulerà, Dino (2019). "Vertebrates and Their Kin". The Dissection of Vertebrates. pp. 1–44. doi:10.1016/B978-0-12-410460-0.00001-2. ISBN 978-0-12-410460-0. Myomeres are the segmented paired muscular blocks that extend through the trunk and tail. Alternating contraction of the musculature of the right and left sides of the body exerts forces on the notochord, noted earlier as a laterally flexible rod, that allow the side-to-side locomotory movements characteristic of less derived chordates and vertebrates. Johnston, I.A. (2008). "The biological basis of variability in the texture of fish flesh". Improving Seafood Products for the Consumer. pp. 465–489. doi:10.1533/9781845694586.5.465. ISBN 978-1-84569-019-9. The fillet is made up of segmentally arranged structures called myotomes or myomeres, the shape of which varies along the length of the body. In three dimensions, the myomeres constitute a series of overlapping cones that are bounded by connective tissue sheets or myocommata called myosepta. Typically, a transverse steak through the fillet will cut through several myotomes at different levels. Each myotome contains a lateral superficial strip of dark muscle primarily composed of slow contracting fibre types that are used for sustained swimming activity (Johnston et al., 1977).
Withdrawal symptoms include headaches, anxiety, tension, depression, insomnia, restlessness, confusion, irritability, sweating, dysphoria, dizziness, derealization, depersonalization, numbness/tingling of extremities, hypersensitivity to light, sound, and smell, perceptual distortions, nausea, vomiting, diarrhea, appetite loss, hallucinations, delirium, seizures, tremor, stomach cramps, myalgia, agitation, palpitations, tachycardia, panic attacks, short-term memory loss, and hyperthermia. It takes about 18–36 hours for lorazepam to be removed from the body.
Sources: en.wikipedia.org
It is a synthetic cyclic peptide designed as an analog of alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors and is best known from research into pigmentation. It is not an approved pharmaceutical product.
No regulatory agency has approved it for any indication. It is encountered as a research chemical sold outside pharmaceutical supply chains. Products marketed this way are not subject to the manufacturing and labeling requirements that apply to approved drugs.
Reports describe increased skin pigmentation as well as side effects such as nausea, flushing, and changes to existing moles. Much of the evidence comes from small studies and case reports rather than large trials. The long-term safety profile is therefore uncertain.
Laboratory confirmation typically combines retention time matching on a chromatographic system with mass measurement. A reference standard of known identity is needed for a meaningful comparison. Sequence-level techniques can add further confirmation.